Venn Life Sciences Holdings Plc (VENN):企業の財務・戦略的SWOT分析

◆英語タイトル:Venn Life Sciences Holdings Plc (VENN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14737
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing solutions. The organization offers drug development services such as clinical pharmacology, drug candidate selection, in-licensing and technical due diligence, non-clinical and pre-clinical development, regulatory affairs and consulting, pharmacometrics and PK and PD modelling, pharmaceutical development, and others. It offers clinical services including feasibility, regulatory affairs, project management, clinical monitoring, biometrics, interactive response technology, resourcing and recruitment, legal services and investigator initiated studies. Venn Life Sciences caters to pharmaceutical, biotechnology and medical device companies and academic organizations. It has operations in the UK, France, the Netherlands, Germany and Ireland. Venn Life Sciences is headquartered in London, the UK.

Venn Life Sciences Holdings Plc Key Recent Developments

Sep 25,2018: Venn Life Sciences Holdings: Interim Results for 6 months ended 30 June 2018
May 17,2018: Venn Life Sciences Holdings: Preliminary Final Results for the year ended 31 December 2017
Mar 21,2018: Venn Life Sciences Holdings Announces Resignation of Director

This comprehensive SWOT profile of Venn Life Sciences Holdings Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Venn Life Sciences Holdings Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Venn Life Sciences Holdings Plc – Key Information
Venn Life Sciences Holdings Plc – Overview
Venn Life Sciences Holdings Plc – Key Employees
Venn Life Sciences Holdings Plc – Key Employee Biographies
Venn Life Sciences Holdings Plc – Key Operational Heads
Venn Life Sciences Holdings Plc – Major Products and Services
Venn Life Sciences Holdings Plc – History
Venn Life Sciences Holdings Plc – Company Statement
Venn Life Sciences Holdings Plc – Locations And Subsidiaries
Venn Life Sciences Holdings Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Venn Life Sciences Holdings Plc – Business Description
Venn Life Sciences Holdings Plc – Corporate Strategy
Venn Life Sciences Holdings Plc – SWOT Analysis
SWOT Analysis – Overview
Venn Life Sciences Holdings Plc – Strengths
Venn Life Sciences Holdings Plc – Weaknesses
Venn Life Sciences Holdings Plc – Opportunities
Venn Life Sciences Holdings Plc – Threats
Venn Life Sciences Holdings Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Venn Life Sciences Holdings Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Venn Life Sciences Holdings Plc, Key Information
Venn Life Sciences Holdings Plc, Key Ratios
Venn Life Sciences Holdings Plc, Share Data
Venn Life Sciences Holdings Plc, Major Products and Services
Venn Life Sciences Holdings Plc, History
Venn Life Sciences Holdings Plc, Key Employees
Venn Life Sciences Holdings Plc, Key Employee Biographies
Venn Life Sciences Holdings Plc, Key Operational Heads
Venn Life Sciences Holdings Plc, Other Locations
Venn Life Sciences Holdings Plc, Subsidiaries
Venn Life Sciences Holdings Plc, Key Manufacturing facilities
Venn Life Sciences Holdings Plc, Key Competitors
Venn Life Sciences Holdings Plc, SWOT Analysis
Venn Life Sciences Holdings Plc, Ratios based on current share price
Venn Life Sciences Holdings Plc, Annual Ratios
Venn Life Sciences Holdings Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Venn Life Sciences Holdings Plc, Performance Chart
Venn Life Sciences Holdings Plc, Ratio Charts

★海外企業調査レポート[Venn Life Sciences Holdings Plc (VENN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pets at Home Group Plc (PETS):企業の財務・戦略的SWOT分析
    Pets at Home Group Plc (PETS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Foster Farms:企業の戦略・SWOT・財務情報
    Foster Farms - Strategy, SWOT and Corporate Finance Report Summary Foster Farms - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • PNM Resources Inc (PNM):企業の財務・戦略的SWOT分析
    PNM Resources Inc (PNM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hypera SA:企業の戦略・SWOT・財務情報
    Hypera SA - Strategy, SWOT and Corporate Finance Report Summary Hypera SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Snyder’s-Lance, Inc.:戦略・SWOT・企業財務分析
    Snyder's-Lance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Snyder's-Lance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Societatea Nationala Nuclearelectrica SA (SNN):企業の財務・戦略的SWOT分析
    Societatea Nationala Nuclearelectrica SA (SNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Milestone Scientific Inc (MLSS)-医療機器分野:企業M&A・提携分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments. The company provides medical products and dental products. Its medical products include epidurals, intra-articular injections, …
  • European Institute of Oncology-製薬・医療分野:企業M&A・提携分析
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …
  • Smith & Nephew plc:企業の戦略・SWOT・財務分析
    Smith & Nephew plc - Strategy, SWOT and Corporate Finance Report Summary Smith & Nephew plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Broncus Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc is a medical device company that develops navigation, diagnostic and therapeutic technologies for the treatment of patients with lung disease. The company offers Archimedes system, a total lung access platform used for virtual …
  • Hankyu Hanshin Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hankyu Hanshin Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hankyu Hanshin Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Tryton Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Tryton Medical Inc (Tryton Medical) is a medical device company that develops novel stent systems for the treatment of bifurcation lesions. The company offers tryton side branch coronary artery stent which is designed to treat, protect and secure coronary bifurcations. Its tryton side branch …
  • Tenet Healthcare Corporation:企業の戦略・SWOT・財務分析
    Tenet Healthcare Corporation - Strategy, SWOT and Corporate Finance Report Summary Tenet Healthcare Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Qatar Electricity & Water Company QSC (QEWS)-エネルギー分野:企業M&A・提携分析
    Summary Qatar Electricity & Water Company QSC (QEWC) is an energy utility. The company generates electricity and desalinates water. It owns and operates various power generation and water desalination stations: QEWC also has interests in all power and water companies in the country. The State of Qat …
  • Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Avidity Biosciences LLC (Avidity Biosciences), formerly Avidity NanoMedicines LLC is a biotech company that develops antibody oligonucleotide conjugates (AOCs). The company’s proprietary platform technology has enhanced pharmacokinetic and biodistribution properties that improves the deliver …
  • Aurizon Holdings Limited:企業の戦略・SWOT・財務情報
    Aurizon Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Aurizon Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bechtle AG (BC8):企業の財務・戦略的SWOT分析
    Summary Bechtle AG (Bechtle) is an information technology (IT) products retailer. The company offers various productswhich include notebooks, tablets, smartphones, mobile phones, wearables, power banks, spare parts, accessories, monitors, public display, projectors, input devises, scanners, barcode …
  • TaiMed Biologics Inc (4147):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiMed Biologics Inc (TMB) is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases. The company provides pipeline products such as TMB-355, TMB-607 and TMB-571, among others. It offers TMB-355 which is a proprietary humanized ant …
  • Severn Glocon Group Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Severn Glocon Group Plc (Severn Glocon), formerly Sageshire Ltd is a designer and manufacturer of engineered valve products. The company offers control, choke, and subsea valves; small bore subsea valves and actuators; filters and dryers; low-friction valve actuators, engineered valves, meta …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆